ArticleBMC public health2026
Incidence and trends for notifiable infectious diseases in Shenyang, China, 2005-2024.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfectious diseases remain a major global public health challenge. Evolving epidemiological patterns and considerable regional variation underscore the need for localized, real-time surveillance and assessment. This study examines the incidence and trends of notifiable infectious diseases (NIDs) in Shenyang from 2005 to 2024 to generate an evidence base for regional and national public health strategy formulation.
methodsThe data of NIDs in Shenyang from January 1, 2005 to December 31, 2024 were obtained from the National Notifiable Diseases Reporting System (NNDRS). Joinpoint regression analysis was used to determine the changing trend of annual incidence.
resultsBetween 2005 and 2024, Shenyang reported 668,476 cases of 33 notifiable infectious diseases, all classified as Class B (58.8%) or C (41.2%). Respiratory infections were the most common (47.4%), followed by fecal-oral (29.8%) and blood-borne/sexual transmission (21.7%). The overall annual age-standardized incidence rate (ASIR) averaged 481.49 per 100,000 population, increasing significantly from 360.72 to 880.18 per 100,000 over the 20-year period (AAPC: 6.20%; 95%CI: 2.11%,10.04%), representing a 144% overall rise. Males exhibited a higher average annual ASIR (565.30 per 100,000) compared to females (393.35 per 100,000). A pronounced upward trend was observed in Class C diseases (AAPC: 12.75%; 95%CI: 7.47%,18.19%), whereas Class B diseases remained stable. Respiratory-transmitted diseases showed the strongest growth (AAPC: 12.75%; 95%CI: 7.47%,18.19%), followed by those transmitted via the fecal-oral route (AAPC: 4.79%; 95%CI: 0.42%,9.65%), while blood-borne/sexually transmitted diseases declined slightly (AAPC: -2.52%; 95%CI: -4.11%,-0.30%). Vaccine-preventable diseases (VPDs) declined markedly (AAPC: -6.98%; 95%CI: -8.62%,-5.30%), in contrast to a substantial increase in non-VPDs (AAPC: 13.66%; 95%CI: 10.04%,17.68%).
conclusionsThe overall incidence of NIDs in Shenyang was lower than the national average, however, the respiratory infections pose a relatively high disease burden and warrant focused control. It is noteworthy that the incidence of VPDs has declined significantly over the past two decades, suggesting a possible beneficial impact of immunization strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.